SE0400378D0 - Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet - Google Patents

Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet

Info

Publication number
SE0400378D0
SE0400378D0 SE0400378A SE0400378A SE0400378D0 SE 0400378 D0 SE0400378 D0 SE 0400378D0 SE 0400378 A SE0400378 A SE 0400378A SE 0400378 A SE0400378 A SE 0400378A SE 0400378 D0 SE0400378 D0 SE 0400378D0
Authority
SE
Sweden
Prior art keywords
zonisamide
osa
sleep
treat
agents
Prior art date
Application number
SE0400378A
Other languages
English (en)
Swedish (sv)
Inventor
Jan Hedner
Ludger Grote
Kaj Stenloef
Original Assignee
Jan Hedner
Ludger Grote
Kaj Stenloef
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Hedner, Ludger Grote, Kaj Stenloef filed Critical Jan Hedner
Priority to SE0400378A priority Critical patent/SE0400378D0/xx
Publication of SE0400378D0 publication Critical patent/SE0400378D0/xx
Priority to DK05711057T priority patent/DK1715859T3/da
Priority to EP05711057A priority patent/EP1715859B1/en
Priority to US10/598,114 priority patent/US7655681B2/en
Priority to CNB2005800049089A priority patent/CN100558358C/zh
Priority to SI200530544T priority patent/SI1715859T1/sl
Priority to NZ548943A priority patent/NZ548943A/en
Priority to AU2005212149A priority patent/AU2005212149B2/en
Priority to ES05711057T priority patent/ES2317196T3/es
Priority to PCT/SE2005/000196 priority patent/WO2005077362A1/en
Priority to CA2555149A priority patent/CA2555149C/en
Priority to JP2006553094A priority patent/JP2007523079A/ja
Priority to AT05711057T priority patent/ATE410163T1/de
Priority to DE602005010213T priority patent/DE602005010213D1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Test And Diagnosis Of Digital Computers (AREA)
SE0400378A 2004-02-17 2004-02-17 Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet SE0400378D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE0400378A SE0400378D0 (sv) 2004-02-17 2004-02-17 Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
DE602005010213T DE602005010213D1 (de) 2004-02-17 2005-02-15 Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens
NZ548943A NZ548943A (en) 2004-02-17 2005-02-15 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
EP05711057A EP1715859B1 (en) 2004-02-17 2005-02-15 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
US10/598,114 US7655681B2 (en) 2004-02-17 2005-02-15 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
CNB2005800049089A CN100558358C (zh) 2004-02-17 2005-02-15 唑尼沙胺在制备用于治疗或预防阻塞性睡眠呼吸暂停的药物中的应用
SI200530544T SI1715859T1 (sl) 2004-02-17 2005-02-15 Postopek za zdravljenje in diagnosticiranje motenega dihanja med spanjem z uporabo zonisamida in sredstvo za izvedbo postopka
DK05711057T DK1715859T3 (da) 2004-02-17 2005-02-15 Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden
AU2005212149A AU2005212149B2 (en) 2004-02-17 2005-02-15 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
ES05711057T ES2317196T3 (es) 2004-02-17 2005-02-15 Metodo para tratar y diagnosticar la respiracion irregular durante el sueño usando zonisamida y medio para llevar a cabo el metodo.
PCT/SE2005/000196 WO2005077362A1 (en) 2004-02-17 2005-02-15 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
CA2555149A CA2555149C (en) 2004-02-17 2005-02-15 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
JP2006553094A JP2007523079A (ja) 2004-02-17 2005-02-15 睡眠障害性呼吸の治療および診断方法、およびこの方法を実施する手段
AT05711057T ATE410163T1 (de) 2004-02-17 2005-02-15 Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400378A SE0400378D0 (sv) 2004-02-17 2004-02-17 Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet

Publications (1)

Publication Number Publication Date
SE0400378D0 true SE0400378D0 (sv) 2004-02-17

Family

ID=31974257

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0400378A SE0400378D0 (sv) 2004-02-17 2004-02-17 Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet

Country Status (14)

Country Link
US (1) US7655681B2 (xx)
EP (1) EP1715859B1 (xx)
JP (1) JP2007523079A (xx)
CN (1) CN100558358C (xx)
AT (1) ATE410163T1 (xx)
AU (1) AU2005212149B2 (xx)
CA (1) CA2555149C (xx)
DE (1) DE602005010213D1 (xx)
DK (1) DK1715859T3 (xx)
ES (1) ES2317196T3 (xx)
NZ (1) NZ548943A (xx)
SE (1) SE0400378D0 (xx)
SI (1) SI1715859T1 (xx)
WO (1) WO2005077362A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2522708C (en) 2003-04-29 2013-05-28 Orexigen Therapeutics, Inc. Compositions for affecting weight loss
JP2009508854A (ja) * 2005-09-16 2009-03-05 セリューサイエンス アーベー 睡眠時呼吸障害の予防及び治療方法及び手段
CN101370488B (zh) 2005-11-22 2012-07-18 奥雷西根治疗公司 增加胰岛素敏感性的组合物
WO2007062228A1 (en) * 2005-11-28 2007-05-31 Orexigen Therapeutics, Inc. Sustained-release formulation of zonisamide
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
JP2010508997A (ja) 2006-11-09 2010-03-25 オレキシジェン・セラピューティクス・インコーポレーテッド 減量薬を投与するための方法
WO2009158114A1 (en) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
BR112012016799A2 (pt) * 2010-01-07 2019-10-08 Vivus Inc tratamento da síndrome de apneia obstrutiva do sono com uma combinação de um inibidor da anidrase carbônica e um agente ativo adicional
RU2616496C2 (ru) 2010-01-11 2017-04-17 Ориксиджен Терапьютикс, Инк. Способы проведения терапии потери веса у пациентов с доминирующей депрессией (варианты)
WO2013177621A1 (en) 2012-05-30 2013-12-05 Resmed Sensor Technologies Limited Method and apparatus for monitoring cardio-pulmonary health
DK2858640T3 (da) 2012-06-06 2020-06-29 Nalpropion Pharmaceuticals Llc Sammensætning til anvendelse i en fremgangsmåde til behandling af overvægt og fedme hos patienter med høj cardiovaskulær risiko
US10525219B2 (en) 2012-06-26 2020-01-07 Resmed Sensor Technologies Limited Methods and apparatus for monitoring and treating respiratory insufficiency
CA3016110C (en) 2016-05-11 2020-09-01 Jan Hedner Sultiame for the treatment of sleep apnea
CN112259179A (zh) * 2020-10-09 2021-01-22 首都医科大学宣武医院 一种患者日志生成方法及装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019321A2 (en) * 1999-09-15 2001-03-22 Elan Pharmaceuticals, Inc. Methods for treating neuropathic pain using hetreoarylmethanesulfonamides
SE0000601D0 (sv) * 2000-02-24 2000-02-24 Jan Hedner Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
US7109198B2 (en) * 2002-05-17 2006-09-19 Duke University Method for treating obesity

Also Published As

Publication number Publication date
DE602005010213D1 (de) 2008-11-20
NZ548943A (en) 2010-06-25
US7655681B2 (en) 2010-02-02
AU2005212149A1 (en) 2005-08-25
AU2005212149B2 (en) 2010-02-11
CA2555149A1 (en) 2005-08-25
EP1715859B1 (en) 2008-10-08
ES2317196T3 (es) 2009-04-16
CA2555149C (en) 2014-01-21
WO2005077362A1 (en) 2005-08-25
EP1715859A1 (en) 2006-11-02
ATE410163T1 (de) 2008-10-15
DK1715859T3 (da) 2009-02-16
SI1715859T1 (sl) 2009-06-30
US20070281005A1 (en) 2007-12-06
CN100558358C (zh) 2009-11-11
CN1917874A (zh) 2007-02-21
JP2007523079A (ja) 2007-08-16

Similar Documents

Publication Publication Date Title
DK1715859T3 (da) Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden
CY1122533T1 (el) Ανακινρα για χρηση στην αντιμετωπιση συνδρομου αποφρακτικης βρογχιολιτιδας
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
EA200700214A1 (ru) Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией
EA200800663A1 (ru) Способ и средство профилактики и лечения нарушенного дыхания во время сна
NO20054767L (no) Sammensetninger omfattende apomorfin for inhalering i lunge
NZ567441A (en) Agents that bind a target in pulmonary tissue for treating respiratory diseases.
WO2008022189A3 (en) Administration of high potency platinum compound formulations by inhalation
ATE330589T1 (de) Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege
DE602005018763D1 (de) Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität
EA200800533A1 (ru) Пульсационный ингалятор и способ лечения заболеваний верхних дыхательных путей
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
NO20064964L (no) Behandling av svekket respiratorisk funksjon
MX2012007813A (es) Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
SE0000601D0 (sv) Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
NZ612063A (en) Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
NZ541745A (en) (spiro[8-azaniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-4[hydroxydiphenylacetyl)oxy]chloride (1a, 3b, 5a)) containing compositions
BR112012020185A2 (pt) uso de preparações de heparina oral para tratar doenças e afecções do trato urinário.
JP2013510187A (ja) 誘発されたジスキネジアを治療又は予防するためのキセノンベースの吸入可能薬物
EA201170405A1 (ru) Монотерпены для лечения заболеваний дыхательных путей, в частности, бронхолегочных заболеваний
EA200701077A1 (ru) Применение конъюгатов липидов при лечении заболеваний
WO2006063038A3 (en) Treating sleep deprivation using anesthetic agent
Dehghani Firoozabadi et al. Prevention of nausea and vomiting: methods and utility after surgery in cancer patients?
RU2009141168A (ru) Способы и композиции, содержащие дезвенлафаксин или дулоксетин, для лечения расстройств дыхания во время сна
JP2010523662A5 (xx)